logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Vijay H Naringrekar

This inventor holds 18 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Bristol-Myers Squibb Compnay, Otsuka Pharmaceutical Company, Limited, Celgene Corporation. Active years: 2006-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vijay H Naringrekar. Retrieved from https://idiyas.com/inventor/vijay-h-naringrekar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 77.8



Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 198(Granted Patents)


Location History:

  • Paramus, NJ (US) (2006)
  • Princeton, NJ (US) (2009 - 2019)

Company Filing History:

goldMedal8 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal6 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents
bronzeMedal4 out of 561 
 
Celgene Corporation
 patents

Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Protein Formulations
Romidepsin
Aripiprazole
Controlled Release
Injectable Formulations
Sustained Release
Pharmaceutical Compositions
Epothilones
C-21 Modified Derivatives
GLP-1 Receptor Modulators
18 patents (USPTO):Explore Patents
1. 10265401 - Stable subcutaneous protein formulations and uses thereof (2019-04-23),
2. 9795650 - Romidepsin formulations and uses thereof (2017-10-24),
3. 9782451 - Romidepsin formulations and uses thereof (2017-10-10),
4. 9763935 - Controlled release sterile injectable aripiprazole formulation and method (2017-09-19),
5. 9468664 - Romidepsin formulations and uses thereof (2016-10-18),
6. 9463215 - Romidepsin formulations and uses thereof (2016-10-11),
7. 9309316 - Stable subcutaneous protein formulations and uses thereof (2016-04-12),
8. 8999952 - Aripiprazole complex formulation and method (2015-04-07),
9. 8952013 - Controlled release sterile injectable aripiprazole formulation and method (2015-02-10),
10. 8871227 - Process and formulation containing epothilones and analogs thereof (2014-10-28),
11. 8722679 - Controlled release sterile injectable aripiprazole formulation and method (2014-05-13),
12. 8476239 - Stable protein formulations (2013-07-02),
13. 8030313 - Controlled release sterile injectable aripiprazole formulation and method (2011-10-04),
14. 7807680 - Controlled release sterile injectable aripiprazole formulation and method (2010-10-05),
15. 7550445 - Aripiprazole complex formulation and method (2009-06-23),

Title: Vijay H Naringrekar - Pioneering Inventor from Princeton

Introduction: Vijay H Naringrekar is a distinguished inventor based in Princeton, NJ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Vijay H Naringrekar holds several patents in the areas of renewable energy technologies, advanced materials, and medical devices, showcasing his versatility and ingenuity in inventing solutions for diverse challenges.

Career Highlights: With a career spanning over two decades, Vijay H Naringrekar has worked with renowned research institutions and leading companies, consistently pushing the boundaries of technological advancements. His inventions have significantly impacted industries such as healthcare, clean energy, and telecommunications.

Collaborations: Throughout his career, Vijay H Naringrekar has collaborated with top scientists, engineers, and experts in multidisciplinary projects, fostering a culture of innovation and knowledge exchange. His collaborative efforts have led to the development of cutting-edge solutions with real-world applications.

Conclusion: Vijay H Naringrekar's passion for innovation, coupled with his technical expertise, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of inventors and researchers to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…